Ryan Hisner
ryanhisner.bsky.social
Ryan Hisner
@ryanhisner.bsky.social
Teacher. Learner. Investigating mysteries of SARS-CoV-2 evolution. LongDesertTrain on another platform.
Fascinating 🧵. The grotesquely mutated spike of this NJ Cryptic binds ACE2 very tightly.

It raises a broader question: Can cryptic wastewater-like lineages transmit?

YES

We knew it happened once. Now we know it's happened at least twice. The results in both cases were not pretty. 1/15
This is wild.
Remember the NJ crytic lineage?
I posted 18 months ago that the Spike was too divergent to predict ACE2 binding, and asked if someone else could figure it out.
Some colleagues took me up on it.
Guess what they found?
1/
November 22, 2025 at 7:19 PM
Reposted by Ryan Hisner
I think the number of downloads is not a good measure, because often I just quickly check something in the tree, I look for a certain mutation, a certain time and variant circulation, or take a screenshot of a tree for a talk. This was, and still is such an important resource!!
November 17, 2025 at 10:37 AM
Reposted by Ryan Hisner
Important read on challenges of continued SARS-CoV-2 surveillance provided by tools like Nextstrain, using GISAID data. Just one comment as someone who is using Nextstrain for my research, for keeping up to date and for scientific talks:
nextstrain.org/blog/2025-11...
Nextstrain: Interruption to GISAID-based SARS-CoV-2 sequence analyses
Nextstrain blog post from 2025-11-06; author(s): Trevor Bedford, Richard Neher and the Nextstrain team
nextstrain.org
November 17, 2025 at 10:37 AM
Excellent thread by @snpoehlm.bsky.social on BA.3.2, summarizing their recent study and outlining where we currently stand.

Two BA.3.2 sequences (of 67 total) showed up from New South Wales today, as BA.3.2 continues its creeping geographical spread.
Our recent study on BA.3.2 is now available. Thanks to Markus Hoffmann, Lu Zhang and Georg Behrens for the great collaboration. Here’s a brief summary of our findings:
November 17, 2025 at 11:30 AM
Reposted by Ryan Hisner
Incredible story with echoes of frank abagnale jr. Apparently a guy pathologically obsessed with his reputation has established a record of building trust with researchers more understandably concerned with proper credit for their work, but the, uh, drawbacks of the arrangement remain unresolved.
November 16, 2025 at 6:59 PM
Reposted by Ryan Hisner
And for no reason... or rather no reason that can be stated publicly without revealing sordid ulterior motives—namely the monopolization of viral genomic data & analysis in the hands of Peter Bogner, a non-scientist & lifelong con artist who wields absolute power at GISAID. It's a tragedy & a farce.
November 16, 2025 at 6:56 PM
Reposted by Ryan Hisner
I’ve used WA Health’s COVID-19 wastewater surveillance page to estimate the number of infections of BA.3.2.

I estimate ~300 BA.3.2.* infections in Perth for the latest week, and ~6,000 across the 12 weeks since BA.3.2.* was first detected.

#COVID19 #SARSCoV2 #BA_3_2 #Australia #WA #Perth
🧵
November 15, 2025 at 1:29 AM
BA.3.2.2 nearly 50% of recent Western Australia sequences—perhaps on a path to dominance there?

In this latest batch, there's another furin-cleavage site (FCS)-adjacent ∆QT sequence. It's very closely related to the first one, so there's now no doubt that the deletion is real. 1/3
November 13, 2025 at 12:23 AM
Reposted by Ryan Hisner
1/ Pretty amazing new results showing an unexpected benefit of mRNA vaccines. Patients who received a COVID-19 mRNA vaccine within 100 days of starting immune checkpoint inhibitor (ICI) therapy survived almost twice as long. jenndowd.substack.com/p/can-mrna-v... #episky #medsky #cancer
November 10, 2025 at 12:12 PM
Reposted by Ryan Hisner
Do you remember BA.3—the weakling cousin of BA.1 & BA.2 that seemed to take the worst from each & had weaker ACE2 binding than even the ancestral Wuhan Virus?

After three years, BA.3 is back.

And it is transmitting.

Who saw this coming?
1/13
November 9, 2025 at 6:41 PM
Can't emphasize how damaging this is. A single non-scientist—Peter Bogner—holds all power & makes all decisions at GISAID & provides no justifications for any of them, except blatantly false ones.

He has that power because he conned rich & powerful people into giving it to him. Enough.
I want to spell this out in case the implications aren't clear:

This means all public tools/webapps of GISAID data (all the ones you've been used to seeing thru the pandemic, as far as we can tell) are prohibited.

The file allowed this. Cut that - cut off all tools the public & others were using.
On Oct 1, 2025, GISAID informed us that they had ended updates to the flat file of SARS-CoV-2 genomic sequences and associated metadata that we had used to update Nextstrain analyses since Feb 2020. GISAID's stated rationale was that their "resources are limited". 1/5
November 10, 2025 at 2:46 AM
Reposted by Ryan Hisner
Continued surveillance and variant analysis is important, as highlighted by the emergence and spread of BA.3.2. Lack of data sharing by GISAID is bad news.
GISAID on providing data to @Nextstrain.org: "After consulting with our staff and advisors on the feasibility of keeping your global tree up-to-date, there was a clear consensus that continuing to generate, zip and move big files back and forth is not sustainable and a waste of resources."
🙃
Nextstrain: Interruption to GISAID-based SARS-CoV-2 sequence analyses
Nextstrain blog post from 2025-11-06; author(s): Trevor Bedford, Richard Neher and the Nextstrain team
next.nextstrain.org
November 6, 2025 at 10:14 PM
This is a total outrage and has crippled SARS-CoV-2 variant tracking and evolutionary analysis.

Updating a file and giving access to Nextstrain & Cov-Spectrum does not require extensive resources, so the official justification is a lie. There has to be an ulterior motive here.
Nextstrain's daily-updated tree of SARS-CoV-2 genomes was my gateway into the world of viral phylogenetics in early 2020, and Nextstrain's beautiful interactive tree display is crucial to making usher.bio results usable. GISAID cutting off data harms global surveillance efforts. 🧵👇
On Oct 1, 2025, GISAID informed us that they had ended updates to the flat file of SARS-CoV-2 genomic sequences and associated metadata that we had used to update Nextstrain analyses since Feb 2020. GISAID's stated rationale was that their "resources are limited". 1/5
November 7, 2025 at 12:18 PM
BA.3.2 has arrived in the UK. One BA.3.2.2, collected October 5, was uploaded from Scotland today.

Same branch as recent BA.3.2.2 from Germany & Slovenia.

It has a few errors (S:ins214:ASDT is misread & ORF1a:E4388K is an artifact). Ignoring those, the one notable new mutation is N:N126K.
November 7, 2025 at 12:10 PM
Reposted by Ryan Hisner
One of the greatest. I recently saw a car with a bumper sticker that said "Remember the Edmund Fitzgerald."

www.youtube.com/watch?v=FuzT...
Gordon Lightfoot - Wreck Of The Edmund Fitzgerald (Official Audio)
YouTube video by Gordon Lightfoot
www.youtube.com
November 3, 2025 at 2:24 AM
Reposted by Ryan Hisner
BA.3.2 made it to New Zealand 👀
🦠Heads up. BA.3.2 has arrived in NZ

BA.3.2 detected in Aotearoa New Zealand wastewater
3.2% for the week to 5 October

BA.3.2 is not shown in the fortnight to 19 Oct. However, variants with a national percentage of < 1% are not included so BA.3.2 is likely to still be circulating
October 30, 2025 at 9:57 AM
Reposted by Ryan Hisner
The cellular protease TMPRSS2 cleaves and activates the SARS-CoV-2 spike protein, priming it for membrane fusion and viral entry.
This step is essential for efficient infection of airway epithelial cells.
October 27, 2025 at 10:11 PM
First-world problem, I know, but I can't stand it when supplementary information is contained in 20 different files that have to be individually downloaded and viewed. Why not put it all in one PDF?
October 25, 2025 at 3:16 PM
I can't reply to this comment, so I guess I'll quote-reply.

The most recent molnupiravir sequences have indeed been from Australia, with the MOV stats for the most recent being pictured below.

Once again, we see strong evidence that MOV-induced mutations are being positively selected. 1/4
October 25, 2025 at 2:43 PM
BA.3.2.1 still hanging out in the Netherlands. Nothing new in spike in this latest one, though 3/4 nucleotide mutations are nonsynonymous (amino acid-changing) and all are in NSP3.
One more BA.3.2.1 from netherlands

cc @snpoehlm.bsky.social @ryanhisner.bsky.social @josetteschoenma.bsky.social ( i m apparently blocked by X, likely it doesn't like intl law)
October 23, 2025 at 4:39 PM
I beg to differ! If it's not a sequencing mistake—and it looks clean—one of these BA.3.2 has something completely novel in SARS-CoV-2 evolution: an FCS-adjacent deletion!

One of the two QT repeats appears to have been deleted. I've never seen anything like this before. BA.3.2 is a different beast.
October 22, 2025 at 11:46 AM
Due to antigenic imprinting (also called "original antigenic sin", or OAS) the antibody response is slow to turn, but turn it will, with enough repeated, UPDATED vaccinations.

Or repeated infections, I suppose, if you prefer suffering and poor health.
October 21, 2025 at 12:12 PM
Reminiscent of Thorstein Veblen's work. Jobs with "no taint of usefulness" are the most respectable—and the most highly paid—while manual labor or anything smacking of usefulness "is of course on a precarious footing as regards respectability"—and, it goes without saying, are poorly paid.
October 20, 2025 at 11:29 AM
Bad. No justification, no communication, no standard procedures for making changes—just arbitrary pronouncements cutting off access to some of the most valuable resources we have.
And now NextStrain as well.

Next up, will GISAID start charging open-source community tools to have access?

That would completely shaft users who contributed to GISAID, where we never agreed to that and assumed GISAID would be good custodians of the data we contributed. They're not.
October 17, 2025 at 8:34 PM
Reposted by Ryan Hisner
#BA32 remains detectable in a substantial fraction of Perth clinical samples for the week ending Oct 5, though total sequence and case numbers remain low.
October 16, 2025 at 5:13 PM